{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:16:36Z","timestamp":1788412596747,"version":"build-2803163510"},"reference-count":74,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cancer therapy-related acute kidney injury has become an increasingly common challenge as modern treatments prolong survival and increase exposure to potentially nephrotoxic therapies. Decisions regarding therapeutic rechallenge have relied on normalizing serum creatinine and recovering estimated glomerular filtration rate, despite growing evidence that biochemical recovery does not necessarily indicate restoration of kidney integrity or resilience. In this review, we propose biological kidney recovery as a conceptual framework that integrates mechanisms of kidney injury and repair (adaptive and maladaptive) with emerging biomarkers and therapeutic rechallenge. We first summarize the distinct mechanisms of kidney injury induced by platinum-based chemotherapy, immune checkpoint inhibitors, and vascular endothelial growth factor pathway inhibitors, highlighting how these differences influence subsequent repair. We then discuss the cellular and metabolic processes underlying adaptive repair, the transition to maladaptive remodeling, and current approaches for assessing biological recovery through pathology, biomarkers, and multi-omics technologies. Finally, we present a practical framework for individualized therapeutic rechallenge based on an integrated assessment of kidney-, tumor-, and patient-related factors and outline future directions for precision onco-nephrology. By shifting the focus from filtration alone to biological recovery, this framework enables more informed therapeutic rechallenge aimed at preserving both oncologic efficacy and long-term kidney health.<\/jats:p>","DOI":"10.3390\/cells15171563","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:33:52Z","timestamp":1787942032000},"page":"1563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cellular Recovery and Therapeutic Rechallenge After Cancer Therapy-Induced Kidney Injury: Mechanistic Insights and Clinical Implications"],"prefix":"10.3390","volume":"15","author":[{"given":"Yosuke","family":"Dotsu","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-0453","authenticated-orcid":false,"given":"Kazumasa","family":"Akagi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan"},{"name":"Clinical Oncology Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6143-1205","authenticated-orcid":false,"given":"Midori","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan"},{"name":"Clinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan"},{"name":"Clinical Oncology Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan"},{"name":"Clinical Genomics Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0373-0618","authenticated-orcid":false,"given":"Shinnosuke","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagasaki University Hospital, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra1613984","article-title":"Acute Kidney Injury in Patients with Cancer","volume":"376","author":"Rosner","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.02780312","article-title":"Onco-nephrology: Renal toxicities of chemotherapeutic agents","volume":"7","author":"Perazella","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ekir.2020.10.002","article-title":"A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease","volume":"6","author":"Kitchlu","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.xkme.2021.08.008","article-title":"Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management","volume":"3","author":"Seethapathy","year":"2021","journal-title":"Kidney Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of Renal Fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15874","DOI":"10.1073\/pnas.2005477117","article-title":"Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury","volume":"117","author":"Kirita","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/onco.13925","article-title":"Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease","volume":"26","author":"Wong","year":"2021","journal-title":"Oncologist"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clgc.2015.10.005","article-title":"Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated with Perioperative Cisplatin","volume":"14","author":"Locke","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.21037\/tlcr-2026-1-0097","article-title":"Cisplatin re-challenge following recovery from carboplatin-induced, biopsy-proven acute tubular necrosis in a 57-year-old patient with squamous-transformed non-small cell lung cancer: A case report","volume":"15","author":"Morikawa","year":"2026","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"967826","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.etp.2008.09.003","article-title":"Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity","volume":"61","author":"Chirino","year":"2009","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","article-title":"Cisplatin and hypomagnesemia","volume":"25","author":"Lajer","year":"1999","journal-title":"Cancer Treat. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16836","DOI":"10.1073\/pnas.1415518111","article-title":"Synchronized renal tubular cell death involves ferroptosis","volume":"111","author":"Linkermann","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar","year":"2016","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ckj\/sfab052","article-title":"Checkpoint inhibitor therapy-associated acute kidney injury: Time to move on to evidence-based recommendations","volume":"14","author":"Perazella","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Van Wynsberghe, M., Flejeo, J., Sakhi, H., Ollero, M., Sahali, D., Izzedine, H., and Henique, C. (2021). Nephrotoxicity of Anti-Angiogenic Therapies. Diagnostics, 11.","DOI":"10.3390\/diagnostics11040640"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): An 8-year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","article-title":"VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"652","DOI":"10.34067\/KID.0000000749","article-title":"Acute Kidney Injury Associated with Novel Anticancer Therapies: Immunotherapy","volume":"6","author":"Karam","year":"2025","journal-title":"Kidney360"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1681\/ASN.2019070676","article-title":"Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study","volume":"31","author":"Cortazar","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.34067\/KID.0003962021","article-title":"Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO","volume":"3","author":"Herrmann","year":"2022","journal-title":"Kidney360"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fenoglio, R., Cozzi, M., Del Vecchio, G., Sciascia, S., Barreca, A., Comandone, A., and Roccatello, D. (2023). The need for kidney biopsy in the management of side effects of target and immunotherapy. Front. Nephrol., 3.","DOI":"10.3389\/fneph.2023.1043874"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.kint.2017.07.030","article-title":"Cellular and molecular pathways of renal repair after acute kidney injury","volume":"93","author":"Kumar","year":"2018","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MNH.0000000000000893","article-title":"Proximal tubule responses to injury: Interrogation by single-cell transcriptomics","volume":"32","author":"McMahon","year":"2023","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MNH.0000000000000605","article-title":"Acute kidney injury and maladaptive tubular repair leading to renal fibrosis","volume":"29","author":"Yu","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1073\/pnas.1310653110","article-title":"Differentiated kidney epithelial cells repair injured proximal tubule","volume":"111","author":"Kusaba","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.celrep.2015.07.034","article-title":"Sox9 Activation Highlights a Cellular Pathway of Renal Repair in the Acutely Injured Mammalian Kidney","volume":"12","author":"Kumar","year":"2015","journal-title":"Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2026684118","DOI":"10.1073\/pnas.2026684118","article-title":"Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury","volume":"118","author":"Gerhardt","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000363715","article-title":"Mitochondrial biogenesis in the acutely injured kidney","volume":"127","author":"Tran","year":"2014","journal-title":"Nephron Clin. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00285.2020","article-title":"MAmerican Journal of Physiology-Renal Physiologyitochondrial dysfunction and the AKI-to-CKD transition","volume":"319","author":"Jiang","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fontecha-Barriuso, M., Lopez-Diaz, A.M., Guerrero-Mauvecin, J., Miguel, V., Ramos, A.M., Sanchez-Ni\u00f1o, M.D., Ruiz-Ortega, M., Ortiz, A., and Sanz, A.B. (2022). Tubular Mitochondrial Dysfunction, Oxidative Stress, and Progression of Chronic Kidney Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11071356"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2013.09.026","article-title":"Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1\/PGC-1\u03b1 activation following ischemia-reperfusion injury","volume":"273","author":"Funk","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","article-title":"Cellular senescence: The good, the bad and the unknown","volume":"18","author":"Huang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.34067\/KID.0000000000000316","article-title":"Targeting Senescent Cells as Therapy for CKD","volume":"5","author":"Mylonas","year":"2024","journal-title":"Kidney360"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41581-024-00834-0","article-title":"Epithelial cell states associated with kidney and allograft injury","volume":"20","author":"Hinze","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41581-024-00875-5","article-title":"Lymphocytes and innate immune cells in acute kidney injury and repair","volume":"20","author":"Lee","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: Components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"F788","DOI":"10.1152\/ajprenal.00184.2024","article-title":"Transition from acute kidney injury to chronic kidney disease: Mechanisms, models, and biomarkers","volume":"327","author":"Zhang","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2019209","DOI":"10.1001\/jamanetworkopen.2020.19209","article-title":"Recommendations on Acute Kidney Injury Biomarkers from the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement","volume":"3","author":"Ostermann","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13613-024-01360-9","article-title":"Biomarkers in acute kidney injury","volume":"14","author":"Ostermann","year":"2024","journal-title":"Ann. Intensive Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1681\/ASN.2012070653","article-title":"Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely","volume":"24","author":"Chen","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","article-title":"Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury","volume":"286","author":"Ichimura","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1172\/JCI45361","article-title":"Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis","volume":"123","author":"Humphreys","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit. Care"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.ki.5002721","article-title":"Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery","volume":"73","author":"Portilla","year":"2008","journal-title":"Kidney Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00134-019-05919-0","article-title":"Identification and validation of biomarkers of persistent acute kidney injury: The RUBY study","volume":"46","author":"Hoste","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-021-03618-1","article-title":"External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury","volume":"25","author":"Bagshaw","year":"2021","journal-title":"Crit. Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","article-title":"Early detection of acute renal failure by serum cystatin C","volume":"66","author":"Marggraf","year":"2004","journal-title":"Kidney Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamainternmed.2019.6390","article-title":"Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study","volume":"180","author":"Hsu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.kint.2017.07.007","article-title":"Acute kidney injury is a risk factor for subsequent proteinuria","volume":"93","author":"Parr","year":"2018","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41581-022-00586-9","article-title":"Extracellular vesicles in kidney disease","volume":"18","author":"Grange","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-023-00725-w","article-title":"Circulating non-coding RNAs in chronic kidney disease and its complications","volume":"19","author":"Zhao","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.34067\/KID.0008002021","article-title":"Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury","volume":"3","author":"Koyner","year":"2022","journal-title":"Kidney360"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","article-title":"Prevention of cisplatin nephrotoxicity: State of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care","volume":"61","author":"Rey","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.kint.2024.09.017","article-title":"Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: A position statement from the American Society of Onco-nephrology","volume":"107","author":"Herrmann","year":"2025","journal-title":"Kidney Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00262-025-04147-4","article-title":"Immune checkpoint inhibitors-associated acute kidney injury: A systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk","volume":"74","author":"Ho","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Corr\u00eaa, L.M.A., Louren\u00e7o, A.L.M., Brand\u00e3o, L.K.V., Mazur, G.R., Barbosa, A.A., Santiago, C.B.G., J\u00fanior, I.F.D., Husch, R.G., Silva, Y.R.D., and de Santana, G.C. (2026). Renal toxicity during VEGF-pathway inhibition in cancer: A practical review of proteinuria, hypertension, and kidney-limited thrombotic microangiopathy. Clin. Transl. Oncol., advance online publication.","DOI":"10.1007\/s12094-026-04487-2"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41581-022-00562-3","article-title":"Artificial intelligence-enabled decision support in nephrology","volume":"18","author":"Loftus","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41581-023-00799-6","article-title":"The dawn of multimodal artificial intelligence in nephrology","volume":"20","author":"Shickel","year":"2024","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/17\/1563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:33:59Z","timestamp":1788410039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/17\/1563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":74,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cells15171563"],"URL":"https:\/\/doi.org\/10.3390\/cells15171563","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}